Bottom line is why would share holders vote for a buy out when you won’t get the opportunity of a lifetime to just ride the wave of Leronlimab. It would be a slap in the face to be offered a buy out when so much is possible with this drug. Nobody can afford to buy us out. We may end up being the biggest pharma of all when all is said and done. I can wait a few short years for cancer indications and all the HIV indications come to fruition. Then what about the autoimmune diseases that Leronlimab can possibly treat or reset. The money potential will not be realized if a buy out happens. It very short sighted to even consider a buy out. Nader estimated a high triple digit stock value with dividends eventually. Why would anyone sell?